Volume 2, Number 2 / April issue 2016
Zeinab A. Rahman, Wedad A. Hassan, Amany El Garhy
The possible protective effects of oxytocin on cisplatin-induced toxicity in female rats

The present study aimed to assess the protective effect of oxytocin against cisplatin-induced liver, renal spleen and ovarian toxicities in female Sprague Dawly rats. Cisplatin (7.5 mg/kg, i.p. single dose) caused significant increase in blood urea, serum creatinine, liver enzymes: AST, ALT and alkaline phosphatase. Cisplatin caused decrease in catalase and reduced glutathione meanwhile it caused increase in the malondialdehyde content of kidney, liver and spleen homogenates. On the other hand, administration of oxytocin (800 µg/kg i.p) for six days with injection of a single dose of cisplatin onset of the day 3, ameliorated the cisplatin-induced nephrotoxicity and hepatotoxicity as indicated by the restoration of kidney, liver functions and oxidative stress biomarkers. Furthermore, oxytocin reduced the histopathological changes induced by cisplatin and caused decreased expression of caspase-3 in immune-histochemical studies of liver, kidney, spleen and ovarian tissues. In conclusion, oxytocin showed protective effects against cisplatin-induced toxicity in female rats due to its antioxidant and immunomodulatory functions.
Keywords: cisplatin, oxytocin, nephrotoxicity, liver enzymes, immunomodulation

Cite this article:
Zeinab A. Rahman, Wedad A. Hassan, Amany El Garhy. The possible protective effects of oxytocin on cisplatin-induced toxicity in female rats. Acta Scientiae et Intellectus, 2(2)2016, 27-38.


  1. Aebi, H. (1984): Methods Enzymol.; 105: 121-126.
  2. Akman T, Akman L, Erbas O, Cosan M, Taskiran D and Ozsaran A (2015): The Preventive Effect of Oxytocin to Cisplatin-Induced Neurotoxicity: An Experimental Rat Model. Bio Med Research International. Research Article. ID 167235, 5 p.
  3. Alizadeh AM, Faghihi M and Khori V (2012): Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore. Peptides.; 36(1): 71-77.
  4. Badary O, Abdel-Maksoud S, Ahmed W and Owieda G (2005): Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci; 76: 2125–2135.
  5. Bancroft J.D, Stevens A and Turner DR (1996): Theory and practice of Histological Techniques. Fourth Ed. Churchill living stone, NewYork, London, San Francisco, Tokyo
  6. Belfield A. and Goldberg D.M. (1971): Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine. Enzyme J. Clin. Path.; 12: 561- 573.
  7. Beutler E, Duron O and Kelly MB (1963): J.Lab. Clin. Med.; 61:882.
  8. Cersosimo, R.J (1993): Hepatotoxicity associated with cisplatin chemotherapy. Annals of Pharmacotherapy 27(4):438-41.
  9. Chirino Y. and Pedraza-Chaverri J. (2009): Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol; 61:223
  10. Deavall D.G, Martin E.A, Horner J.M. and Roberts R (2012): Drug-induced oxidative stress and toxicity. Journal of Toxicology.; 13 pages. 645460
  11. Doumas B.T, Watson W.A and Biggs H.G (1971): Albumin standards and the measurement of serum albumin with bromcresolgreen. Clin. Chim. Acta, 31(1):87-96.
  12. Düşünceli F, Işeri SO, Ercan F, Gedik N, Yeğen C. and Yeğen B.C. (2008): Oxytocin alleviates hepatic ischemia-reperfusion injury in rats. Peptides.; 29(7): 1216-22.
  13. Elberry A.A, Refaie S.M, Kamel M, Ali T, Darwish H. and Ashourg O. (2013): Oxytocin ameliorates cisplatin-induced nephrotoxicity in Wistar rats. Ann Saudi Med 33:57-62.
  14. Erbaş O, Akman L, Yavaşoğlu A, Cosan T.M, Akman T. and Taskiran D. (2014): Oxytocin Improves Follicular Reserve in a Cisplatin-Induced Gonadotoxicity Model in Rats. Biomed Res Int.; 703691
  15. Erbas O, Korkmaz H.A, Oltulu F, Aktug H, Yavasoglu A, Akman L, Solmaz V. and Taskiran D. (2014): Oxytocin alleviates cisplatin-induced renal damage in rats Iran J Basic Med Sci. 17(10): 747–752.
  16. Fawcett J.K and Soctt J.E. (1960): A rapid and precise method for the determination of urea. J. Clin. Path.; 13:156-159.
  17. Gornal A.C, Bardawill C.J and David M.M (1949): J. Biol. Chem.; 177:751.
  18. Gutkowska J. and Jankowski M. (2009): Oxytocin: Old Hormone, New Drug Review. Pharmaceuticals, 2(3), 168-183.
  19. Hassan I, Chibber S and Naseem I (2010): Ameliorative effect of riboflavin on the cisplatin induced nephrotoxicity and hepatotoxicity under photoillumination. Food Chem. Toxicol., 48 (8–9): 2052-2058.
  20. Pabla N. and Dong Z. (2008): Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int; 73:994-100.
  21. Padilla ND, Bleeker WK, Lubbers Y, Rigter GM, Van Mierlo GJ and Daha MR (2003): Rat C-reactive protein activates the autologous complement system. Immunology J; 109:564-571.
  22. Palipoch S. and Punsawad C (2013): Biochemical and Histological Study of Rat Liver and Kidney Injury Induced by Cisplatin. J Toxicol. Pathol. 26: 293–299 Original Article
  23. Ramesh G. and Reeves WB. (2003): TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J. of Renal Physiol.; 285:610–618.
  24. Rashed A L, Hashemb M R and Solimane MH (2011) :Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity.J. of Biomedicine& Pharmacotherapy, V. 65, 7, 474-480.
  25. Reitman S. and Frankel F. (1957): Colorimetric methods for determination of serum glutamic oxalo acetic and glutamic pyruvic transaminase activities. Am. J. Clin. Path., 28: 26 -34.
  26. Satoh, K. (1978): Clinica Chimica Acta, 90:37
  27. Schirmeister, J. (1964): Determination of creatinine in serum. Dtsch. med Wschr.; 89:1940.
  28. Schrier R.W. (2002): Cancer therapy and renal injury. J Clin.Invest; 100:743-745.
  29. Wang P., Yang H., Tiana, S., Wang L., Wangc S., Zhanga F. and Wanga Y. (2015): Oxytocin-secreting system: A major part of the neuroendocrine center regulating immunologic activity Journal of Neuroimmunology, Vol. 289, P. 152-161.
  30. Yucebilgin MS, Terek MC and Ozsaran A (2004): Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Australian and New Zealand Journal of Obstetrics and Gynaecology; 44(1):6-9.